Teva to Resume Production of Critical Pediatric Oncology Drug: Too Little, Too Late
By Beatrice Brown In my last blog post, I reflected on the ethical issues relevant to a critical shortage of a widely used pediatric oncology drug, vincristine. The shortage occurred after one of two pharmaceutical companies producing the drug, Teva, withdrew from the market, and the other, Pfizer, was unable to keep up with the…
